Combining Clinicopathologic and Ultrasonic Features for Predicting Skip Metastasis of Lateral Lymph Nodes in Papillary Thyroid Carcinoma

References

• Mulita F, Anjum F. Thyroid Adenoma. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• Zhang Z, Zhang X, Yin Y, et al. Integrating BRAF mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma. BMC Cancer. 2022;22(1):461. doi:10.1186/s12885-022-09550-z
   PubMed Web of Science ®Google Scholar
• Hauch A, Al-Qurayshi Z, Randolph G, Kandil E. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol. 2014;21(12):3844–3852. doi:10.1245/s10434-014-3846-8
   PubMed Web of Science ®Google Scholar
• Kwak J, Kim E, Chung W, Moon H, Kim M, Choi J. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology. 2009;253(3):854–860. doi:10.1148/radiol.2533090471
   PubMed Web of Science ®Google Scholar
• Colonna M, Uhry Z, Guizard A, et al. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015;39(4):511–518. doi:10.1016/j.canep.2015.04.015
   PubMed Web of Science ®Google Scholar
• Lim H, Devesa S, Sosa J, Check D, Kitahara C. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338–1348. doi:10.1001/jama.2017.2719
   PubMed Web of Science ®Google Scholar
• Lu K, Zhang Y, Da J, et al. A novel scoring system for predicting the metastases of posterior right recurrent laryngeal nerve lymph node involvement in patients with papillary thyroid carcinoma by preoperative ultrasound. Front Endocrinol. 2021;12:738138. doi:10.3389/fendo.2021.738138
   PubMed Web of Science ®Google Scholar
• Zhao M, Shi X, Zou Z, et al. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features. Front Endocrinol. 2023;14:1151505. doi:10.3389/fendo.2023.1151505
   PubMed Web of Science ®Google Scholar
• Haugen B, Alexander E, Bible K, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020
   PubMed Web of Science ®Google Scholar
• Likhterov I, Reis L, Urken M. Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: anatomic pathways of lymphatic spread. Head Neck. 2017;39(5):853–859. doi:10.1002/hed.24568
   PubMed Web of Science ®Google Scholar
• Gimm O, Rath F, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg. 1998;85(2):252–254. doi:10.1046/j.1365-2168.1998.00510.x
   PubMed Web of Science ®Google Scholar
• Lim Y, Koo B. Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma. Oral Oncol. 2012;48(3):262–265. doi:10.1016/j.oraloncology.2011.10.006
   PubMed Web of Science ®Google Scholar
• Nixon I, Wang L, Ganly I, et al. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg. 2016;103(3):218–225. doi:10.1002/bjs.10036
   PubMed Web of Science ®Google Scholar
• Wada N, Duh Q, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237(3):399–407. doi:10.1097/01.sla.0000055273.58908.19
   PubMed Web of Science ®Google Scholar
• Chen B, Zhang Z, Wang K, et al. A multivariable model of BRAF and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manag Res. 2019;11:7211–7217. doi:10.2147/cmar.s199921
   PubMed Web of Science ®Google Scholar
• Alabousi M, Alabousi A, Adham S, et al. Diagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid cancer cervical lymph node metastasis: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(2):107–118. doi:10.1001/jamaoto.2021.3387
   PubMed Web of Science ®Google Scholar
• Xu S, Yao J, Zhou W, Chen L, Zhan W. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019;41(11):3984–3991. doi:10.1002/hed.25941
   PubMed Web of Science ®Google Scholar
• Lee H, Park H, Kim S, et al. Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch Otorhinolaryngol. 2013;270(11):2969–2974. doi:10.1007/s00405-013-2634-6
   PubMed Web of Science ®Google Scholar
• Liu B, Zhang Y, Zhao C, Wang H, Li M, Xu H. Conventional ultrasound characteristics, TI-RADS category and shear wave speed measurement between follicular adenoma and follicular thyroid carcinoma. Clin Hemorheol Microcirc. 2020;75(3):291–301. doi:10.3233/ch-190750
   PubMed Web of Science ®Google Scholar
• Chen B, Zhang Z, Wang K, et al. Association of BRAFV600E mutation with ultrasonographic features and clinicopathologic characteristics of papillary thyroid microcarcinoma: a retrospective study of 116 cases. Clin Hemorheol Microcirc. 2019;73(4):545–552. doi:10.3233/ch-190568
   PubMed Web of Science ®Google Scholar
• Bhaijee F, Nikiforov Y. Molecular analysis of thyroid tumors. Endocr Pathol. 2011;22(3):126–133. doi:10.1007/s12022-011-9170-y
   PubMed Web of Science ®Google Scholar
• Kabaker A, Tublin M, Nikiforov Y, et al. Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma. Thyroid. 2012;22(6):585–589. doi:10.1089/thy.2011.0274
   PubMed Web of Science ®Google Scholar
• Mulita F, Theofanis G, Verras G, et al. Comparison of postoperative bleeding using harmonic scalpel and LigaSure in thyroid surgery: a 15-year single-centre retrospective study. Med Glas. 2023;20(2). doi:10.17392/1629-23
   Google Scholar
• Lamartina L, Grani G, Arvat E, et al. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr Relat Cancer. 2018;25(3):L7–L11. doi:10.1530/erc-17-0453
   PubMed Web of Science ®Google Scholar
• Kim Y, Park W. Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma. World J Surg Oncol. 2012;10:164. doi:10.1186/1477-7819-10-164
   PubMed Web of Science ®Google Scholar
• Moon W, Jung S, Lee J, et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology. 2008;247(3):762–770. doi:10.1148/radiol.2473070944
   PubMed Web of Science ®Google Scholar
• Mulita F, Plachouri M, Liolis E, Vailas M, Panagopoulos K, Maroulis I. Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS). Endokrynol Pol. 2021;72(2):143–144. doi:10.5603/EP.a2021.0018
   PubMed Web of Science ®Google Scholar
• Mulita F, Iliopoulos F, Tsilivigkos C, et al. Cancer rate of Bethesda category II thyroid nodules. Med Glas. 2022;19(1). doi:10.17392/1413-21
   Google Scholar
• Brown R, de Souza J, Cohen E. Thyroid cancer: burden of illness and management of disease. J Cancer. 2011;2:193–199. doi:10.7150/jca.2.193
   PubMed Web of Science ®Google Scholar
• Shaha A. Complications of neck dissection for thyroid cancer. Ann Surg Oncol. 2008;15(2):397–399. doi:10.1245/s10434-007-9724-x
   PubMed Web of Science ®Google Scholar
• Malterling R, Andersson R, Falkmer S, Falkmer U, Niléhn E, Järhult J. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life. Acta oncologica. 2010;49(4):454–459. doi:10.3109/02841860903544600
   PubMed Web of Science ®Google Scholar
• Mulita F, Verras G, Dafnomili V, et al. Thyroidectomy for the management of differentiated thyroid carcinoma and their outcome on early postoperative complications: a 6-year single-centre retrospective study. Chirurgia. 2022;117(5):556–562. doi:10.21614/chirurgia.2736
   PubMed Web of Science ®Google Scholar
• Kim Y. Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma. Otolaryngol Head Neck Surg. 2012;147(1):15–19. doi:10.1177/0194599812439277
   PubMed Web of Science ®Google Scholar
• Roh J, Park J, Rha K, Park C. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma? Head Neck. 2007;29(10):901–906. doi:10.1002/hed.20606
   PubMed Web of Science ®Google Scholar
• Nie X, Tan Z, Ge M. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. BMC Cancer. 2017;17(1):702. doi:10.1186/s12885-017-3698-2
   PubMedGoogle Scholar
• Yang Z, Heng Y, Zhao Q, et al. A specific predicting model for screening skip metastasis from patients with negative central lymph nodes metastasis in papillary thyroid cancer. Front Endocrinol. 2021;12:743900. doi:10.3389/fendo.2021.743900
   PubMed Web of Science ®Google Scholar
• Xiang D, Xie L, Xu Y, Li Z, Hong Y, Wang P. Papillary thyroid microcarcinomas located at the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasis. Surgery. 2015;157(3):526–533. doi:10.1016/j.surg.2014.10.020
   PubMed Web of Science ®Google Scholar
• Attard A, Paladino N, Lo Monte A, et al. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review. BMC Surg. 2019;18(S1):112. doi:10.1186/s12893-018-0435-y
   PubMedGoogle Scholar
• Zhao H, Huang T, Li H. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Surgery. 2019;166(1):55–60. doi:10.1016/j.surg.2019.01.025
   PubMed Web of Science ®Google Scholar
• Zhang F, Zheng B, Yu X, Wang X, Wang S, Teng W. Risk factors for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma: a retrospective study and meta-analysis. Front Endocrinol. 2021;12:675643. doi:10.3389/fendo.2021.675643
   PubMed Web of Science ®Google Scholar
• Lei J, Zhong J, Jiang K, Li Z, Gong R, Zhu J. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma. Oncotarget. 2017;8(16):27022–27033. doi:10.18632/oncotarget.15388
   PubMedGoogle Scholar
• Zhang T, Qi X, Chen J, et al. The association between tumor’s location and cervical lymph nodes metastasis in papillary thyroid cancer. Gland Surgery. 2019;8(5):557–568. doi:10.21037/gs.2019.10.02
   PubMed Web of Science ®Google Scholar
• Lee Y, Shin S, Lim Y, et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer. Head Neck. 2014;36(6):887–891. doi:10.1002/hed.23391
   PubMed Web of Science ®Google Scholar
• Iannuccilli J, Cronan J, Monchik J. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy. J Ultrasound Med. 2004;23(11):1455–1464. doi:10.7863/jum.2004.23.11.1455
   PubMed Web of Science ®Google Scholar
• Buczyńska A, Sidorkiewicz I, Kościuszko M, et al. Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer. Sci Rep. 2023;13(1):13711. doi:10.1038/s41598-023-40898-9
   PubMed Web of Science ®Google Scholar
• Medas F, Canu GL, Cappellacci F, Boi F, Calò PG. Predictive factors of lymph node metastasis in patients with papillary microcarcinoma of the thyroid: retrospective analysis on 293 cases. Front Endocrinol. 2020;11:551. doi:10.3389/fendo.2020.00551
   PubMed Web of Science ®Google Scholar